IRON Disc Medicine, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $3.6B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $1.3M | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $47.0K |
| 2023-Q1 | $15.0M | $0 |
| 2023-Q2 | $0 | $59.0M |
| 2023-Q3 | $0 | $42.8M |
| 2023-Q4 | $0 | $84.7M |
| 2024-Q1 | $0 | $23.5M |
| 2024-Q2 | $14.0M | $157.8K |
| 2024-Q3 | $0 | $262.1K |
| 2024-Q4 | $0 | $4.9M |
| 2025-Q1 | $0 | $42.0M |
| 2025-Q2 | $0 | $693.8K |
| 2025-Q3 | $0 | $7.8M |
| 2025-Q4 | $0 | $96.9M |
| 2026-Q1 | $0 | $3.6M |
| 2026-Q2 | $0 | $6.0M |
| 2026-Q3 | $0 | $12.7M |
| 2026-Q4 | $0 | $4.7M |
Bought$30.3M9 buy days
Sold$389.7M147 sell days
Net insider flow-$359.3Mnet selling · 5 years
Latest trade2026-11-10Savage William Jacob
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Savage William Jacob | Other C-suite | 16,035 | $85.09 | $1.4M | 1 |
| 2026-10-21 | Sell | Bitterman Kevin | Director | 25,519 | $80.23 | $2.0M | 3 |
| 2026-10-20 | Sell | Bitterman Kevin | Director | 5,312 | $79.95 | $424.7K | 3 |
| 2026-10-19 | Sell | Bitterman Kevin | Director | 10,994 | $79.97 | $879.2K | 3 |
| 2026-09-11 | Sell | Bitterman Kevin | Director | 27,136 | $70.11 | $1.9M | 1 |
| 2026-09-04 | Sell | Bitterman Kevin | Director | 1,689 | $79.96 | $135.1K | 3 |
| 2026-09-03 | Sell | Bitterman Kevin | Director | 5,203 | $79.98 | $416.1K | 3 |
| 2026-09-02 | Sell | Bitterman Kevin | Director | 49,164 | $80.17 | $3.9M | 6 |
| 2026-09-01 | Sell | Bitterman Kevin | Director | 129 | $79.95 | $10.3K | 3 |
| 2026-08-25 | Sell | Yu Jonathan Yen-Wen | COO | 8,796 | $83.12 | $731.1K | 1 |
| 2026-08-24 | Sell | Yu Jonathan Yen-Wen | COO | 300 | $82.53 | $24.8K | 1 |
| 2026-08-17 | Sell | Quisel John D | CEO | 33,000 | $79.15 | $2.6M | 3 |
| 2026-08-12 | Sell | Yu Jonathan Yen-Wen | COO | 804 | $82.64 | $66.4K | 1 |
| 2026-08-06 | Sell | Khara Rahul | Other C-suite | 5,000 | $80.00 | $400.0K | 1 |
| 2026-07-13 | Sell | Quisel John D | CEO | 33,000 | $74.96 | $2.5M | 3 |
| 2026-07-07 | Sell | Yu Jonathan Yen-Wen | COO | 100 | $82.50 | $8.2K | 1 |
| 2026-06-29 | Sell | Khara Rahul | Other C-suite | 1,649 | $75.00 | $123.7K | 1 |
| 2026-06-26 | Sell | Khara Rahul | Other C-suite | 851 | $75.00 | $63.8K | 1 |
| 2026-06-26 | Sell | Yu Jonathan Yen-Wen | COO | 300 | $72.50 | $21.8K | 1 |
| 2026-06-22 | Sell | Yu Jonathan Yen-Wen | COO | 9,700 | $72.66 | $704.8K | 1 |
| 2026-06-18 | Sell | Quisel John D | CEO | 34,000 | $70.22 | $2.4M | 3 |
| 2026-06-18 | Sell | Khara Rahul | Other C-suite | 7,500 | $70.22 | $526.7K | 3 |
| 2026-06-16 | Sell | Yu Jonathan Yen-Wen | COO | 18,612 | $69.19 | $1.3M | 2 |
| 2026-04-14 | Sell | Franchi Jean M. | CFO | 6,257 | $69.24 | $433.2K | 1 |
| 2026-04-13 | Sell | Savage William Jacob | Other C-suite | 5,731 | $66.38 | $380.5K | 2 |
| 2026-04-13 | Sell | Franchi Jean M. | CFO | 400 | $69.00 | $27.6K | 1 |
| 2026-03-02 | Sell | Savage William Jacob | Other C-suite | 7,378 | $65.88 | $486.1K | 2 |
| 2026-02-25 | Sell | Franchi Jean M. | CFO | 353 | $69.06 | $24.4K | 1 |
| 2026-02-18 | Sell | Franchi Jean M. | CFO | 7,081 | $65.47 | $463.6K | 2 |
| 2026-02-17 | Sell | Quisel John D | CEO | 13,264 | $62.86 | $833.8K | 1 |
| 2026-02-17 | Sell | Stephenson Pamela | Other C-suite | 5,531 | $62.86 | $347.7K | 1 |
| 2026-02-17 | Sell | Franchi Jean M. | CFO | 4,075 | $62.86 | $256.2K | 1 |
| 2026-02-17 | Sell | Savage William Jacob | Other C-suite | 3,256 | $62.86 | $204.7K | 1 |
| 2026-02-17 | Sell | Yu Jonathan Yen-Wen | COO | 3,231 | $62.86 | $203.1K | 1 |
| 2026-02-17 | Sell | Khara Rahul | Other C-suite | 2,853 | $62.86 | $179.3K | 1 |
| 2026-01-20 | Sell | Khara Rahul | Other C-suite | 1,000 | $69.74 | $69.7K | 1 |
| 2026-01-02 | Sell | Khara Rahul | Other C-suite | 6,500 | $78.68 | $511.4K | 3 |
| 2025-12-17 | Sell | Bitterman Kevin | Director | 754 | $91.47 | $69.0K | 3 |
| 2025-12-16 | Sell | Bitterman Kevin | Director | 68,923 | $91.24 | $6.3M | 3 |
| 2025-12-15 | Sell | Bitterman Kevin | Director | 69,693 | $91.34 | $6.4M | 7 |
| 2025-12-15 | Sell | Savage William Jacob | Other C-suite | 13,093 | $91.22 | $1.2M | 3 |
| 2025-12-12 | Sell | Bitterman Kevin | Director | 45,507 | $92.39 | $4.2M | 9 |
| 2025-12-11 | Sell | Quisel John D | CEO | 40,000 | $93.05 | $3.7M | 4 |
| 2025-11-11 | Sell | Yu Jonathan Yen-Wen | COO | 30,000 | $84.70 | $2.5M | 4 |
| 2025-10-22 | Sell | Blavatnik Len | 10% owner | 744,047 | $80.47 | $59.9M | 1 |
| 2025-10-17 | Sell | Bitterman Kevin | Director | 50,160 | $89.11 | $4.5M | 9 |
| 2025-10-16 | Sell | Bitterman Kevin | Director | 1,425 | $77.11 | $109.9K | 1 |
| 2025-10-15 | Sell | Bitterman Kevin | Director | 22,160 | $77.23 | $1.7M | 2 |
| 2025-10-08 | Sell | Bitterman Kevin | Director | 71,961 | $70.58 | $5.1M | 5 |
| 2025-10-07 | Sell | Bitterman Kevin | Director | 18,039 | $68.38 | $1.2M | 2 |
| 2025-08-22 | Sell | Bitterman Kevin | Director | 2,287 | $61.03 | $139.6K | 1 |
| 2025-08-14 | Sell | Bitterman Kevin | Director | 7,212 | $60.99 | $439.9K | 1 |
| 2025-08-13 | Sell | Bitterman Kevin | Director | 24,962 | $61.15 | $1.5M | 1 |
| 2025-08-05 | Sell | Bitterman Kevin | Director | 395 | $60.95 | $24.1K | 1 |
| 2025-07-30 | Sell | Bitterman Kevin | Director | 8,492 | $61.04 | $518.4K | 1 |
| 2025-07-24 | Sell | Bitterman Kevin | Director | 13,033 | $61.17 | $797.2K | 1 |
| 2025-07-23 | Sell | Bitterman Kevin | Director | 29,837 | $60.97 | $1.8M | 1 |
| 2025-07-18 | Sell | Bitterman Kevin | Director | 664 | $61.13 | $40.6K | 1 |
| 2025-07-17 | Sell | Franchi Jean M. | CFO | 2,031 | $59.00 | $119.8K | 1 |
| 2025-07-10 | Sell | Franchi Jean M. | CFO | 2,000 | $57.50 | $115.0K | 1 |
| 2025-07-09 | Sell | Quisel John D | CEO | 34,800 | $55.33 | $1.9M | 2 |
| 2025-07-03 | Sell | Quisel John D | CEO | 5,200 | $55.09 | $286.5K | 1 |
| 2025-06-16 | Sell | Franchi Jean M. | CFO | 2,000 | $52.26 | $104.5K | 1 |
| 2025-06-06 | Sell | Savage William Jacob | Other C-suite | 2,996 | $50.00 | $149.8K | 1 |
| 2025-05-20 | Sell | Savage William Jacob | Other C-suite | 6,677 | $50.04 | $334.1K | 1 |
| 2025-05-02 | Sell | Savage William Jacob | Other C-suite | 2,100 | $50.17 | $105.4K | 1 |
| 2025-03-24 | Sell | Ashiya Mona | Director | 5,738 | $54.11 | $310.5K | 3 |
| 2025-03-24 | Sell | ORBIMED ADVISORS LLC | Director | 5,738 | $54.11 | $310.5K | 3 |
| 2025-03-21 | Sell | Ashiya Mona | Director | 10,011 | $54.00 | $540.6K | 3 |
| 2025-03-21 | Sell | ORBIMED ADVISORS LLC | Director | 10,011 | $54.00 | $540.6K | 3 |
| 2025-03-20 | Sell | Ashiya Mona | Director | 2,762 | $54.01 | $149.2K | 3 |
| 2025-03-20 | Sell | ORBIMED ADVISORS LLC | Director | 2,762 | $54.01 | $149.2K | 3 |
| 2025-03-19 | Sell | ORBIMED ADVISORS LLC | Director | 39,656 | $54.02 | $2.1M | 3 |
| 2025-03-19 | Sell | Ashiya Mona | Director | 39,656 | $54.02 | $2.1M | 3 |
| 2025-03-12 | Sell | ORBIMED ADVISORS LLC | Director | 83,182 | $54.45 | $4.5M | 6 |
| 2025-03-12 | Sell | Ashiya Mona | Director | 83,182 | $54.45 | $4.5M | 6 |
| 2025-03-11 | Sell | ORBIMED ADVISORS LLC | Director | 27,056 | $54.01 | $1.5M | 3 |
| 2025-03-11 | Sell | Ashiya Mona | Director | 27,056 | $54.01 | $1.5M | 3 |
| 2025-03-10 | Sell | Ashiya Mona | Director | 202,146 | $54.29 | $11.0M | 6 |
| 2025-03-10 | Sell | ORBIMED ADVISORS LLC | Director | 202,146 | $54.29 | $11.0M | 6 |
| 2025-02-18 | Sell | Quisel John D | CEO | 5,574 | $54.58 | $304.2K | 1 |
| 2025-02-18 | Sell | Stephenson Pamela | Other C-suite | 3,137 | $54.58 | $171.2K | 1 |
| 2025-02-18 | Sell | Franchi Jean M. | CFO | 3,136 | $54.58 | $171.2K | 1 |
| 2025-02-18 | Sell | Savage William Jacob | Other C-suite | 1,638 | $54.58 | $89.4K | 1 |
| 2025-02-18 | Sell | Yu Jonathan Yen-Wen | COO | 1,610 | $54.58 | $87.9K | 1 |
| 2025-02-18 | Sell | Khara Rahul | Other C-suite | 1,161 | $54.58 | $63.4K | 1 |
| 2025-02-03 | Sell | Khara Rahul | Other C-suite | 7,500 | $55.55 | $416.6K | 2 |
| 2025-01-02 | Sell | Khara Rahul | Other C-suite | 7,500 | $62.75 | $470.6K | 3 |
| 2024-12-30 | Sell | Quisel John D | CEO | 13,012 | $61.95 | $806.1K | 2 |
| 2024-12-23 | Sell | Quisel John D | CEO | 19,820 | $63.14 | $1.3M | 3 |
| 2024-12-16 | Sell | Quisel John D | CEO | 12,791 | $66.01 | $844.3K | 4 |
| 2024-12-02 | Sell | White William Richard | Director | 1,957 | $64.63 | $126.5K | 3 |
| 2024-11-25 | Sell | Savage William Jacob | Other C-suite | 14,183 | $65.46 | $928.4K | 3 |
| 2024-11-15 | Sell | Savage William Jacob | Other C-suite | 9,158 | $59.64 | $546.2K | 3 |
| 2024-11-04 | Sell | White William Richard | Director | 7,136 | $58.60 | $418.2K | 2 |
| 2024-11-01 | Sell | White William Richard | Director | 201 | $46.37 | $9.3K | 2 |
| 2024-10-01 | Sell | White William Richard | Director | 201 | $51.31 | $10.3K | 4 |
| 2024-09-16 | Sell | Savage William Jacob | Other C-suite | 1,500 | $47.41 | $71.1K | 1 |
| 2024-09-03 | Sell | White William Richard | Director | 1,957 | $49.65 | $97.2K | 4 |
| 2024-09-03 | Sell | Savage William Jacob | Other C-suite | 1,500 | $50.59 | $75.9K | 1 |
| 2024-08-01 | Sell | White William Richard | Director | 201 | $43.44 | $8.7K | 2 |
| 2024-07-01 | Sell | White William Richard | Director | 201 | $46.04 | $9.3K | 3 |
| 2024-06-17 | Buy | Bitterman Kevin | Director | 222,223 | $36.00 | $8.0M | 1 |
| 2024-06-17 | Buy | Ashiya Mona | Director | 83,334 | $36.00 | $3.0M | 3 |
| 2024-06-17 | Buy | ORBIMED ADVISORS LLC | Director | 83,334 | $36.00 | $3.0M | 3 |
| 2024-06-03 | Sell | White William Richard | Director | 1,957 | $36.08 | $70.6K | 3 |
| 2024-05-01 | Sell | White William Richard | Director | 201 | $28.63 | $5.8K | 2 |
| 2024-04-11 | Sell | White William Richard | Director | 2,560 | $31.80 | $81.4K | 2 |
| 2024-03-05 | Sell | Bitterman Kevin | Director | 26,157 | $73.50 | $1.9M | 1 |
| 2024-01-23 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 150,000 | $67.65 | $10.1M | 3 |
| 2024-01-23 | Sell | Bitterman Kevin | Director | 102,500 | $67.65 | $6.9M | 2 |
| 2024-01-10 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 50,000 | $64.00 | $3.2M | 2 |
| 2024-01-10 | Sell | Bitterman Kevin | Director | 20,000 | $64.00 | $1.3M | 1 |
| 2023-12-18 | Sell | ORBIMED ADVISORS LLC | Director | 1,724 | $59.24 | $102.1K | 1 |
| 2023-12-18 | Sell | Ashiya Mona | Director | 1,724 | $59.24 | $102.1K | 1 |
| 2023-12-14 | Sell | Ashiya Mona | Director | 433,300 | $56.75 | $24.6M | 4 |
| 2023-12-14 | Sell | ORBIMED ADVISORS LLC | Director | 433,300 | $56.75 | $24.6M | 4 |
| 2023-12-14 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 51,374 | $58.28 | $3.0M | 4 |
| 2023-12-14 | Sell | Bitterman Kevin | Director | 20,549 | $58.28 | $1.2M | 2 |
| 2023-12-13 | Sell | Ashiya Mona | Director | 106,700 | $58.56 | $6.2M | 3 |
| 2023-12-13 | Sell | ORBIMED ADVISORS LLC | Director | 106,700 | $58.56 | $6.2M | 3 |
| 2023-12-13 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 8,871 | $60.00 | $532.2K | 4 |
| 2023-12-13 | Sell | Bitterman Kevin | Director | 3,548 | $60.00 | $212.9K | 2 |
| 2023-12-12 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 129,918 | $62.80 | $8.2M | 14 |
| 2023-12-12 | Sell | Bitterman Kevin | Director | 51,967 | $62.80 | $3.3M | 7 |
| 2023-12-12 | Sell | White William Richard | Director | 33,511 | $63.21 | $2.1M | 4 |
| 2023-12-12 | Sell | Ashiya Mona | Director | 27,300 | $60.16 | $1.6M | 3 |
| 2023-12-12 | Sell | ORBIMED ADVISORS LLC | Director | 27,300 | $60.16 | $1.6M | 3 |
| 2023-12-12 | Sell | Bryce Joanne | CFO | 2,500 | $65.22 | $163.0K | 1 |
| 2023-12-05 | Sell | Bryce Joanne | CFO | 2,541 | $56.00 | $142.3K | 3 |
| 2023-11-22 | Sell | Khara Rahul | General counsel | 10,000 | $51.74 | $517.4K | 2 |
| 2023-11-14 | Sell | Khara Rahul | General counsel | 4,900 | $50.61 | $248.0K | 2 |
| 2023-11-03 | Sell | Khara Rahul | General counsel | 100 | $50.00 | $5.0K | 1 |
| 2023-09-16 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 2,115 | $53.22 | $112.6K | 1 |
| 2023-09-15 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 260,894 | $53.16 | $13.9M | 1 |
| 2023-09-14 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 94,440 | $53.05 | $5.0M | 1 |
| 2023-09-01 | Sell | Bryce Joanne | CFO | 1,000 | $52.99 | $53.0K | 1 |
| 2023-08-15 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 184,000 | $52.40 | $9.6M | 2 |
| 2023-08-15 | Sell | Bitterman Kevin | Director | 72,931 | $52.40 | $3.8M | 1 |
| 2023-08-15 | Sell | Savage William Jacob | Other C-suite | 7,672 | $52.95 | $406.2K | 3 |
| 2023-08-14 | Sell | Atlas Venture Fund X, L.P. | 10% owner | 175,000 | $52.59 | $9.2M | 3 |
| 2023-08-09 | Sell | Savage William Jacob | Other C-suite | 8,269 | $49.83 | $412.1K | 3 |
| 2023-08-01 | Sell | Bryce Joanne | CFO | 4,521 | $49.91 | $225.6K | 2 |
| 2023-06-30 | Sell | MacDonald Brian Richard | Other C-suite | 4,324 | $45.04 | $194.8K | 2 |
| 2023-06-29 | Sell | MacDonald Brian Richard | Other C-suite | 5,100 | $45.78 | $233.5K | 4 |
| 2023-06-28 | Sell | Novo Holdings A/S | 10% owner | 1,250,000 | $46.10 | $57.6M | 1 |
| 2023-06-28 | Sell | Bryce Joanne | CFO | 10,072 | $49.95 | $503.1K | 3 |
| 2023-06-28 | Sell | MacDonald Brian Richard | Other C-suite | 5,100 | $49.96 | $254.8K | 3 |
| 2023-06-28 | Sell | Savage William Jacob | Other C-suite | 4,384 | $49.98 | $219.1K | 3 |
| 2023-02-15 | Buy | Blavatnik Len | 10% owner | 434,783 | $23.00 | $10.0M | 1 |
| 2023-02-15 | Buy | ORBIMED ADVISORS LLC | Director | 108,696 | $23.00 | $2.5M | 3 |
| 2023-02-15 | Buy | Ashiya Mona | Director | 108,696 | $23.00 | $2.5M | 3 |
| 2022-10-26 | Sell | Leonard Braden Michael | 10% owner | 22,500 | $2.09 | $47.0K | 1 |
| 2022-04-13 | Buy | Leonard Braden Michael | 10% owner | 191,769 | $1.52 | $291.5K | 1 |
| 2022-04-12 | Buy | Leonard Braden Michael | 10% owner | 258,744 | $1.41 | $364.7K | 2 |
| 2022-04-11 | Buy | Leonard Braden Michael | 10% owner | 504,487 | $1.35 | $681.1K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Bitterman Kevin | Director | $8.0M | $63.2M | 2026-10-21 |
| Blavatnik Len | 10% owner | $10.0M | $59.9M | 2025-10-22 |
| Atlas Venture Fund X, L.P. | 10% owner | $0 | $62.9M | 2024-01-23 |
| Ashiya Mona | Director | $5.5M | $52.7M | 2025-03-24 |
| ORBIMED ADVISORS LLC | Director | $5.5M | $52.7M | 2025-03-24 |
| Novo Holdings A/S | 10% owner | $0 | $57.6M | 2023-06-28 |
| Quisel John D | CEO | $0 | $17.4M | 2026-08-17 |
| Savage William Jacob | Other C-suite | $0 | $7.0M | 2026-11-10 |
| Yu Jonathan Yen-Wen | COO | $0 | $5.7M | 2026-08-25 |
| Khara Rahul | Other C-suite | $0 | $3.6M | 2026-08-06 |
| White William Richard | Director | $0 | $3.0M | 2024-12-02 |
| Franchi Jean M. | CFO | $0 | $1.7M | 2026-04-14 |
| Leonard Braden Michael | 10% owner | $1.3M | $47.0K | 2022-10-26 |
| Bryce Joanne | CFO | $0 | $1.1M | 2023-12-12 |
| MacDonald Brian Richard | Other C-suite | $0 | $683.0K | 2023-06-30 |
| Stephenson Pamela | Other C-suite | $0 | $518.9K | 2026-02-17 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-06-17 | 3 | $14.0M | 48 | -5.7% (+5.7% raw) | -0.6% (+10.2% raw) | +33.6% (+44.2% raw) | closed |
| 2023-02-15 | 3 | $15.0M | 54 | -2.6% (-12.6% raw) | +41.7% (+35.5% raw) | +125.1% (+122.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.